Cavan M. Redmond Oncocyte Corp (OCX) insider trading activity

OCX Quotes by TradingView

Cavan M. Redmond is Director of Oncocyte Corp. Currently has a direct ownership of 120,863 shares of OCX, which is worth approximately $264,689. The most recent transaction as insider was on Jun 24, 2022, when has been sold 10,000 shares (Common Stock, No Par Value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 121K
0% 3M change
0% 12M change
Total Value Held $264,689

Cavan M. Redmond Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2022
BUY
Exercise of conversion of derivative security
-
10,000 Added 7.64%
120,863 Common Stock, No Par V...
Mar 16 2022
BUY
Open market or private purchase
$47,600 $1.19 p/Share
40,000 Added 26.51%
110,863 Common Stock, No Par V...
Dec 11 2020
BUY
Grant, award, or other acquisition
-
18,416 Added 20.63%
70,863 Common Stock
CMR

Cavan M. Redmond

Director
Irvine, CA

Track Institutional and Insider Activities on OCX

Follow Oncocyte Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCX shares.

Notify only if

Insider Trading

Get notified when an Oncocyte Corp insider buys or sells OCX shares.

Notify only if

News

Receive news related to Oncocyte Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OCX